Clinical Data news from FierceBiotech
NewsClinical Data inks $66M deal to acquire Adenosine
Clinical Data is buyout out the privately held Adenosine Therapeutics for $11 million, promissory notes totaling $25.2 million and up to $30 million in milestones. The acquisition of Adenosine Read more...
SPOTLIGHT: Clinical Data upbeat on antidepressant
Shares of Clinical Data got a modest boost on the news that its late-stage study of the antidepressant Vilazodone produced positive results. A companion pharmacogenetic test may make it easier to Read more...
| Press ReleasesPRESS RELEASE: Clinical Data Announces Positive Results from Phase III Pivotal Trial of Vilazodone for Depression Clinical Data Announces Positive Results from Phase III Pivotal Trial of Vilazodone for Depression Study Met Both Primary and Secondary Efficacy Endpoints Potential Genetic Biomarkers for Predicting Read more... |
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets